Portugal · Venture startup

Who invested in AceCann

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Wellness

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2024, from 1 source

Latest round
VentureJan 2024
Investors
1
See who backed them

The rounds

  1. Jan 2024
    VentureAmount undisclosed

    Source recorded

Founders and team

From AceCann's own website: 10 on the team.

  • Ivanshu ShantilalCEO
  • Pedro GomesCEO
  • Andreia RaimundoHead of Post-Harvest and Manufacturing
  • Duarte AlcobiaHead of Sales
  • Filipe PereiraHead of Extraction
  • Luis Brito e AbreuHead of Finance and Special Projects
  • Karan WadheraManaging partner Casa Verde
  • Miguel PinóiaFacility Manager
  • Patrícia SilvaCompliance and Quality Assurance Manager
  • Yoni MeyerCasa Verde / Board Member

AdvisersChris MayleMarc Gare

Everyone who backed them

LINCE CAPITALVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists AceCann as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Casa Verde CapitalVC firmPer its own site

Quick answers about AceCann

Who invested in AceCann?

AceCann's investors include LINCE CAPITAL.

How much has AceCann raised?

AceCann has raised 1 round since 2024, none with a disclosed amount.

When did AceCann last raise?

AceCann's most recent round was a Venture in Jan 2024.

Who backed AceCann first?

AceCann's first round on record, in Jan 2024, was backed by LINCE CAPITAL.

What stage is AceCann at?

AceCann's latest named round is a Venture, in Jan 2024.

Where is AceCann based?

AceCann is based in Portugal.

Companies like AceCann

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.